Table of Contents

• 1.1 List of Tables 9
• 1.2 List of Figures 22

2 Introduction 23

• 2.1 Coronary Stents Overview 23

3 Products under Development 24

• 3.1 Coronary Stents - Pipeline Products by Stage of Development 24
• 3.2 Coronary Stents - Pipeline Products by Segment 25
• 3.3 Coronary Stents - Pipeline Products by Territory 26
• 3.4 Coronary Stents - Pipeline Products by Regulatory Path 27
• 3.5 Coronary Stents - Pipeline Products by Estimated Approval Date 28
• 3.6 Coronary Stents - Ongoing Clinical Trials 29

4 Coronary Stents - Pipeline Products under Development by Companies 30

• 4.1 Coronary Stents Companies - Pipeline Products by Stage of Development 30
• 4.2 Coronary Stents - Pipeline Products by Stage of Development 34

5 Coronary Stents Companies and Product Overview 39

• 5.1 Aachen Resonance GmbH Company Overview 39
  • 5.1.1 Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview 39
• 5.2 Abbott Vascular Inc Company Overview 40
  • 5.2.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 40
• 5.3 Adcomp Technologies Inc. Company Overview 48
  • 5.3.1 Adcomp Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
• 5.4 Advanced Bifurcation Systems Inc Company Overview 49
  • 5.4.1 Advanced Bifurcation Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 49
• 5.5 Aeon Bioscience Company Overview 51
  • 5.5.1 Aeon Bioscience Pipeline Products & Ongoing Clinical Trials Overview 51
• 5.6 AlviMedica Medical Technologies Inc Company Overview 52
  • 5.6.1 AlviMedica Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 52
• 5.7 Amaranth Medical Inc Company Overview 63
  • 5.7.1 Amaranth Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 63
• 5.8 Arterius Ltd Company Overview 72
  • 5.8.1 Arterius Ltd Pipeline Products & Ongoing Clinical Trials Overview 72
• 5.9 Atrium Medical Corp Company Overview 73
  • 5.9.1 Atrium Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 73
• 5.10 Axordia Ltd (Inactive) Company Overview 74
  • 5.10.1 Axordia Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 74
• 5.11 B. Braun Melsungen AG Company Overview 75
  • 5.11.1 B. Braun Melsungen AG Pipeline Products & Ongoing Clinical Trials Overview 75
• 5.12 Bactiguard Holding AB Company Overview 76
  • 5.12.1 Bactiguard Holding AB Pipeline Products & Ongoing Clinical Trials Overview 76
• 5.13 Bionext Biotech Products Ltd. Company Overview 77
  • 5.13.1 Bionext Biotech Products Ltd. Pipeline Products & Ongoing Clinical Trials Overview 77
• 5.14 Biosensors International Group Ltd Company Overview 78
  • 5.14.1 Biosensors International Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 78
• 5.15 Biosten, LLC Company Overview 85
  • 5.15.1 Biosten, LLC Pipeline Products & Ongoing Clinical Trials Overview 85
• 5.16 Biotronik AG Company Overview 86
  • 5.16.1 Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview 86
• 5.17 Biotronik SE & Co KG Company Overview 111
  • 5.17.1 Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview 111
• 5.18 Boston Scientific Corp Company Overview 113
  • 5.18.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 113
• 5.19 Cardionovum GmbH Company Overview 123
  • 5.19.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview 123
• 5.20 Cardiorev Pte Ltd (Inactive) Company Overview 127
  • 5.20.1 Cardiorev Pte Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 127

6 Coronary Stents- Recent Developments 269

• 6.1 Nov 27, 2019: Indian stent-maker SMT acquires majority stake in Zarek 269
• 6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 269
• 6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 272
• 6.4 Nov 13, 2019: Abbott announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020 273
• 6.5 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships 274

7 Appendix 406

• 7.1 Methodology 406
• 7.2 About GlobalData 409
• 7.3 Contact Us 409

Coronary Stents - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Coronary Stents - Medical Devices Pipeline Assessment, 2019" provides an overview of Coronary Stents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coronary Stents pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Coronary Stents under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Coronary Stents and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Coronary Stents under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date